The North American Symptomatic Carotid Endarterectomy Trial: Surgical results in 1415 patients

Stroke

Volumn 30, Issue 9, 1999, Pages 1751-1758

  Ferguson, Gary G ^a,b   Eliasziw, Michael ^a,b   Barr, Hugh W K ^b   Clagett, G Patrick ^c   Barnes, Robert W ^d   Wallace, M Christopher ^e   Taylor, D Wayne ^f   Haynes, R Brian ^f   Finan, Jane W ^a   Hachinski, Vladimir C ^b   Barnett, Henry J M ^a,b  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^e UNIVERSITY OF TORONTO   (Canada)

^f MCMASTER UNIVERSITY   (Canada)

Author keywords

Carotid endarterectomy; Complications; Risk factors

Indexed keywords

ADULT; AGED; ARTICLE; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; STROKE; SURGICAL MORTALITY; SURGICAL RISK; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 0032853007     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.30.9.1751     Document Type: Article

References (21)

1. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade stenosis. N Engl J Med. 1991;325:445-453.
2. Barnett HJM, Taylor DW, Eliasziw M, Fox AJ, Ferguson GG, Haynes RB, Rankin RN, Clagett GP, Hachinski VC, Sackett DL, Thorpe KE, Meldrum HE, for the North American Symptomatic Carotid Endarterectomy Trial Collaborators. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. N Engl J Med. 1998;339: 1415-1425.
3. European Carotid Surgery Trialists' Collaborative Group. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. Lancet. 1991; 337:1235-1243.
4. European Carotid Surgery Trialists' Collaborative Group. Endarterectomy for the moderate symptomatic carotid stenosis: interim results from the MRC European Carotid Surgery Trial. Lancet. 1996;347:1591-1593.
5. European Carotid Surgery Trialists' Group. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet. 1998;351:1379-1387.
6. North American Symptomatic Carotid Endarterectomy Trial (NASCET) Steering Committee. North American Symptomatic Carotid Endarterectomy Trial: methods, patient characteristics, and progress. Stroke. 1991;22:711-720.
7. Fox AJ. How to measure carotid stenosis. Radiology. 1993;186:316-318.
8. de Haan R, Limburg M, Bossuyt P, van der Meulen J, Aaronson N. The clinical meaning of Rankin "handicap" grades after stroke. Stroke. 1995; 26:2027-2030.
9. Kleinbaum DG. Survival Analysis: A Self-Learning Text. New York, NY: Springer-Verlag; 1996:104-107.
10. Paciaroni M, Eliasziw M, Kappelle LJ, Finan JW, Ferguson GG, Barnett HJM, for the North American Symptomatic Carotid Endarterectomy Trial (NASCET) Collaborators. Medical complications associated with carotid endarterectomy. Stroke. 1999;30:1759-1763.
11. Rothwell PM, Slattery J, Warlow CP. A systematic review of the risks of stroke and death due to endarterectomy for symptomatic carotid stenosis. Stroke. 1996;27:260-265.
12. Morgenstern LB, Fox AJ, Sharpe BL, Eliasziw M, Barnett HJM, Grotta JC, for the North American Symptomatic Carotid Endarterectomy (NASCET) Group. The risks and benefits of carotid endarterectomy in patients with near occlusion of the carotid artery. Neurology. 1997;48:911-915.
13. Piepgras DG, Morgan MK, Sundt TM Jr, Yanagihara T, Mussman LM. Intracerebral hemorrhage after carotid endarterectomy. J Neurosurg. 1988;68:532-536.
14. Ouriel K, Shortell CK, Illig KA, Greenberg RK, Green RM. Intracerebral hemorrhage after carotid endarterectomy: incidence, contribution to neurologic morbidity, and predictive factors. J Vasc Surg. 1999;29:82-89.
15. Sundt TM Jr, Sandok BA, Whisnant JP. Carotid endarterectomy: complications and preoperative assessment of risk. Mayo Clinic Proc. 1975;50:301-306.
16. Buchan A, Gates P, Pelz D, Barnett HJM. Intraluminal thrombus in the cerebral circulation: implications for surgical management. Stroke. 1988; 19:681-687.
17. Rothwell PM, Slattery J, Warlow CP. Clinical and angiographie predictors of stroke and death from carotid endarterectomy: systematic review. BMJ. 1997;315:1571-1577.
18. Goldstein LB, McCrory DC, Landsman PB, Samsa GP, Ancukiewicz M, Oddone EZ, Matchar DB. Multicenter review of preoperative risk factors for carotid endarterectomy in patients with ipsilateral symptoms. Stroke. 1994;25:1116-1121.
19. Kucey DS, Bowyer B, Iron K, Austin P, Anderson G, Tu JV, for the University of Toronto Carotid Study Group. Determinants of outcome after carotid endarterectomy. J Vasc Surg. 1998;28:1051-1058.
20. Taylor DW, Barnett HJM, Haynes RB, Ferguson GG, Sackett DL, Thorpe KE, Simard D, Silver FL, Hachinski V, Clagett GP, Barnes RW, Spence JD, for the ASA and Carotid Endarterectomy (ACE) Trial Collaborators. Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial. Lancet. 1999;353: 2179-2184.
21. Hertzer NR, Feldman BJ, Beven EG, Tucker HM. A prospective study of the incidence of injury to the cranial nerves during carotid endarterectomy. Surg Gynecol Obstet. 1980;151:781-784.